PA
ATEC icon

PharVision Advisers’s Alphatec Holdings ATEC Stock Holding History

PharVision Advisers’s Portfolio ATEC Stock Details ATEC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$166K Buy
15,222
+3,043
+25% +$44.3K 1.68% 7
2025
Q4 		$256K Buy
+12,179
New +$225K 0.13% 379
2025
Q1 		– Sell
-21,895
Closed -$201K – 283
2024
Q4 		$201K Buy
+21,895
New +$175K 0.17% 308

Other funds holding ATEC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PharVision Advisers's ATEC Position: Q1 2026 in Review

PharVision Advisers increased its Alphatec Holdings (ATEC) stake by 25% in Q1 2026, buying an estimated $44.3K and bringing the position to 15,222 shares worth $166K. The position accounts for 1.68% of the portfolio, ranked #7.

PharVision Advisers first reported a position in ATEC in Q4 2024 and has held it in 3 quarters since. The position peaked at $256K in Q4 2025. 285 funds tracked by Wall St. Rank hold ATEC as of Q1 2026.

  • PharVision Advisers held 15,222 shares of Alphatec Holdings worth $166K as of Q1 2026.
  • PharVision Advisers bought 3,043 Alphatec Holdings shares in Q1 2026, an estimated $44.3K.
  • Alphatec Holdings made up 1.68% of PharVision Advisers's portfolio in Q1 2026, its #7 holding.
  • PharVision Advisers first reported a position in Alphatec Holdings in Q4 2024 and has held it in 3 quarters since.
  • PharVision Advisers's Alphatec Holdings position peaked at $256K in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Alphatec Holdings as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.